VCP interaction with HMGB1 promotes hepatocellular carcinoma progression by activating the PI3K/AKT/mTOR pathway

被引：0
|
作者：
Zhangya Pu
Dan G. Duda
Yuanyuan Zhu
Siya Pei
Xiaofang Wang
Yan Huang
Panpan Yi
Zebing Huang
Fang Peng
Xingwang Hu
Xuegong Fan
机构：
[1] Central South University,Department of Infectious Diseases, Hunan Key Laboratory of Viral Hepatitis, Xiangya Hospital
[2] Central South University,NHC Key Laboratory of Cancer Proteomics, Xiangya Hospital
[3] Massachusetts General Hospital,E.L. Steele Laboratories for Tumor Biology, Department of Radiation Oncology
来源：
Journal of Translational Medicine | / 20卷
关键词：
Hepatocellular carcinoma; VCP; HMGB1; PI3K/AKT/mTOR pathway; Tumor progression;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] VCP interaction with HMGB1 promotes hepatocellular carcinoma progression by activating the PI3K/AKT/mTOR pathway
    Pu, Zhangya
    Duda, Dan G.
    Zhu, Yuanyuan
    Pei, Siya
    Wang, Xiaofang
    Huang, Yan
    Yi, Panpan
    Huang, Zebing
    Peng, Fang
    Hu, Xingwang
    Fan, Xuegong
    JOURNAL OF TRANSLATIONAL MEDICINE, 2022, 20 (01)
  • [2] PODXL promotes malignant progression of hepatocellular carcinoma by activating PI3K/AKT pathway
    Ding, Yifeng
    Wang, Xiaoqing
    Shu, Fei
    Pan, Kehua
    Chen, Xiaohong
    Liu, Qingquan
    JOURNAL OF MOLECULAR HISTOLOGY, 2024, 55 (06) : 1107 - 1120
  • [3] MYO18B promotes hepatocellular carcinoma progression by activating PI3K/AKT/mTOR signaling pathway
    Zhenyu Zhang
    Jinfeng Zhu
    Yansong Huang
    Weibing Li
    Hongqiu Cheng
    Diagnostic Pathology, 13
  • [4] MYO18B promotes hepatocellular carcinoma progression by activating PI3K/AKT/mTOR signaling pathway
    Zhang, Zhenyu
    Zhu, Jinfeng
    Huang, Yansong
    Li, Weibing
    Cheng, Hongqiu
    DIAGNOSTIC PATHOLOGY, 2018, 13
  • [5] LINC00963 promotes hepatocellular carcinoma progression by activating PI3K/AKT pathway
    Wu, J. -H.
    Tian, X. -Y.
    An, Q-M.
    Guan, X. -Y.
    Hao, C. -Y.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (06) : 1645 - 1652
  • [6] GCNT3 Promotes Hepatocellular Carcinoma Progression and EMT by Activating the PI3K/AKT Pathway
    Wang, Yadong
    Fang, Xiaosan
    Xie, Hao
    Wang, Xiaoming
    BIOCHEMICAL GENETICS, 2024,
  • [7] COPS8 promotes hepatocellular carcinoma progression through the PI3K/AKT/mTOR pathway
    Yan, Xiaodong
    Li, Zhongmin
    Tian, Qing
    Zhang, Yamin
    ASIAN JOURNAL OF SURGERY, 2024, 47 (06) : 2947 - 2949
  • [8] Tollip promotes hepatocellular carcinoma progression via PI3K/AKT pathway
    Huang, Lu
    Yang, Qiong
    Chen, Huihong
    Wang, Zhenggeng
    Liu, Qi
    Ai, Shuhua
    OPEN MEDICINE, 2022, 17 (01): : 626 - 637
  • [9] Targeting the PI3K/Akt/mTOR pathway in hepatocellular carcinoma
    Zhou, Qian
    Lui, Vivian W. Y.
    Yeo, Winnie
    FUTURE ONCOLOGY, 2011, 7 (10) : 1149 - 1167
  • [10] Targeting the PI3K/Akt/mTOR Pathway in Hepatocellular Carcinoma
    Sun, Eun Jin
    Wankell, Miriam
    Palamuthusingam, Pranavan
    McFarlane, Craig
    Hebbard, Lionel
    BIOMEDICINES, 2021, 9 (11)
12345